The key to optimal market penetration requires an early and well designed reimbursement strategy that ensures patient access to therapy - Demonstrating product value to patients, physicians and payers is essential with the continuing evolution of evidence-based medicine.
Product value is a key factor in determining whether the new therapy will attain optimal market results. Understanding payer coverage policies and their potential implications on patient access to therapy for a new product must occur during clinical development. Clinical development programs should be aligned with the value proposition and designed to produce clinical endpoints that will support the case for optimal patient access and reimbursement, while limiting access barriers.
PAREXEL's Health Policy and Strategic Reimbursement experts assist pharmaceutical, biotechnology and medical device companies develop strategies in the early stages of product development to understand the impact of evolving federal, state and private healthcare polices will have on product payment and reimbursement. PAREXEL also provides tactical reimbursement and managed market solutions to support commercialized products throughout the product life cycle through reimbursement support programs, help lines and patient assistance programs.
PAREXEL's Health Policy and Strategic Reimbursement Group partners with clients to develop strategic solutions to address market access challenges and overcome barriers to product utilization for biotechnology, pharmaceuticals and medical devices.
Our capabilities include comprehensive services that range from early market and pricing analysis, optimum target indication and means of administration, to coverage and payment issues related to a product's use from private and public third-party payers. We closely monitor the potential impact of new state and federal policies, laws, and regulations, and demonstrate a product's value to public and private payers. Through PAREXEL's exceptional case management services, we remove barriers to product acceptance and provide patients unsurpassed access to care. Our advanced technology platforms allow us to provide interactive web portals and outcomes databases augmenting our Reimbursement HELPlines and Patient Assistance Services.
Examples of our Health Policy and Strategic Reimbursement Services Include:
- Product Market and Pricing Analysis to Ensure Sustainability Throughout a Product's Lifecycle
- Payer Segmentation & Rule Analysis
- Coverage/Payment Policy Analysis & Strategy Development
- Optimal Distribution Model Development
- Creation of Comprehensive Reimbursement Services Materials
- Development of Appropriate Patient Assistance Programs
- Coding Applications - HCPCS/CPT
- Conversion of Trial/EAP Patients to Commercial Product
- Validation of Forecast Assumptions
- Reimbursement Messaging
- Managed Care Dossier Submissions
Examples of Our Reimbursement Support and Patient Access Services Include:
- Reimbursement Support Patient Access
- HELPlines Program Administration
- Prior Authorization Pharmacy Card Programs
- Coding and Claim Assistance
- Voucher Programs
- Benefit Investigations Expanded Access
- Clinical Support Product Distribution
- Adverse Event Reporting
- On-line Access to Prescription Drug Benefits
- Call Center Triage
- Program Data Reporting
